May 20th 2025
HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.
May 1st 2025
‘Wild west’ of pharmaceutical sales developed as patients clamor for GLP-1s for obesity treatment.
April 30th 2025
Novavax continues working with FDA, but case could signal a shift in broader vaccine procedures.
April 17th 2025
Moves prompt praise from opponents of high costs of medications, PBMs.
April 9th 2025
Are your patients' medications about to get more expensive?
Older Americans want Medicare to cover weight-loss drugs, but cost is a sticking point
As obesity medications gain popularity, many older Americans support coverage — but not higher premiums.
‘Global freeloading’ drives up drug prices for Americans, analysis says
Policy center argues patients around the world benefit when Americans pay more than their fair share for research and medicines.
FDA nominee Makary faces scrutiny over vaccine, drug controversies
HELP Committee Senators press Trump’s FDA pick on the cancelled vaccine advisory meeting, mifepristone access, transparency and agency layoffs.
Trump tariffs on imports and effects on health care, explained
President Trump says it’s necessary to impose extra costs on goods from Canada, Mexico and China. What does that mean for the health care sector? Potentially, a lot.
Trump orders ‘radical transparency’ for health care pricing
Executive order says HHS will ‘rapidly enforce’ price disclosures by hospitals, health insurers.
Prescriptions for ivermectin, hydroxychloroquine skyrocketed during the COVID-19 pandemic
UCLA research highlights the widespread use of non-evidence-based treatments during the COVID-19 pandemic, raising concerns about the role of misinformation and health care spending.
Trump plans for Medicaid come up as House subcommittee deliberates on PBM reform
Both sides support revising laws for PBM market, but Democrats and Republicans disagree on potential Medicaid changes.
Preventive antimicrobials: A promising solution to antibiotic resistance
Prevention beats treatment for everyone — patients, payers and investors.
Trump wants RFK Jr. to Make America Healthy Again. This is what they need to know about ultraprocessed foods
A study of the medical economics of ultraprocessed foods, diabetes and pharmaceutical revenues.
Drug prices: Additional provisions to help beneficiaries
A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.
Drug prices: Real benefits for seniors in the Inflation Reduction Act
The obesity drug revolution
What new treatments mean for practices and patients.
Drug prices: Utilization management with insurance and patients
Drug prices: Formulary inclusion vs. formulary placement
Drug prices: Expensive, but for whom?
Drug prices: Another way to interpret negotiations for cost
Drug prices: Introducing research and patient advocacy group AAR
AMR: On diagnosing illness, pharmaceutical companies, and global effects
An expert on antimicrobial resistance discusses how it involves patients in local doctors’ offices and around the world.
Do subscription services for drugs actually work?
Study examined Amazon’s RxPass to see how it affected medication adherence and cost
AMR: Responsibilities of other clinicians
An infectious disease expert describes the state of AMR – and how to fight it.
AMR: Policies and practices that could combat antimicrobial resistance
AMR: Antimicrobial resistance at the patient level
AMR: Antimicrobial resistance in the environment and animals
AMR: Antimicrobial resistance and the importance of vaccines
AMR: An introduction to antimicrobial resistance, part 2
An introduction to antimicrobial resistance, part 1
The Weight Loss Drug Revolution: GLP-1 RA drugs inspire new excitement for metabolic bariatric surgeons
Proponents say the surgical procedures are underutilized and misunderstood in contemporary medicine.
The Weight Loss Drug Revolution: Helping patients avoid phony medicine scams
With high demand but high prices for antiobesity drugs, patients may fall for phony pharmaceuticals.
Trump HHS nominee RFK Jr. – What do voters think?
AP-NORC survey measures approval ratings.
Study highlights significant barriers to access for weight-loss medications for some groups
GLP-1 drugs have proven effective in weight loss, but factors like insurance, what industry you work in, or gender, can all affect access